THE BENEFITS OF HALAL PHARMACEUTICALS STANDARD - MS2424
By
MR. LEONARD ARIFF ABDUL SHATAR
Director, CCM Pharmaceuticals Division
CHEMICAL COMPANY OF MALAYSIA BERHAD
Primary Objectives of Shariah
Preservation
of Faith
Preservation
of Intellect
Preservation
of Progeny
Preservation
of Property
Preservation
of Life
Shariah: Islamic Laws & Ways of Life prescribed by Allah s.w.t
HEALTH/DIETARY
SUPPLEMENTS
Innovator Generics
Those provided by the Pharmaceutical Industry will be of the same standard of Safety, Efficacy
and Quality as defined for medicines and produced in high hygienic conditions.
The Pharmaceutical Industry
Patented products •Off-patent products
MEDICINES
It researches, develops, produces, markets and/or distributes
licensed pharmaceutical products which maintain and
restore health by the prevention and treatment of illnesses.
Halal Products
Halal certified products not only benefit Muslims but
EVERYONE
SAFE for consumption and use
Assurance of product EFFICACY
QUALITY standard of production & ingredients/ materials
HYGIENICALLY processed
because of the WHOLESOMENESS (“THOYYIBAN”) aspects:
IMPORTANCE OF STANDARDS
INDUSTRY’S
PERSPECTIVE
CONSUMER’S
PERSPECTIVE
Source of reference for:
CONSISTENCY of operations
SELF-REGULATION
building CONSUMER CONFIDENCE
MULTI-MARKET access
Independent 3rd party ASSURANCE on:
Consistency product SAFETY,
EFFICACY & QUALITY
HYGIENIC manufacturing process
RESPONSIBLE & ETHICAL
operations
=> INCREASE TRANSPARENCY & RELIABILITY of certification process
Halal Pharmaceutical Standard
HALAL
PHARMACEUTICALS
STANDARD APPROVED
HALAL MATERIAL
LIST
SHARIAH GMP
(PIC/S GUIDELINES)
ALIGNMENT
WHY THE NEED FOR HALAL
PHARMACEUTICAL STANDARD?
Facilitate Lobbying for Halal Logo to be on Primary Packaging
Halal Pharmaceutical Standard: The Development Process
*Source: Guide to the Malaysian Standards System
Starting point of MS 2424
• Pharmaceutical Inspection Co-operation Scheme (PIC/s)
– The Pharmaceutical Inspection Convention and Pharmaceutical
Inspection Co-operation Scheme (jointly referred to as PIC/S)
are two international instruments between countries and
pharmaceutical inspection authorities, which provide together an
active and constructive co-operation in the field of GMP
• Member Countries
Europe Non-European
– 28 Countries - Argentina, Australia, Canada
Israel, South Africa, the USA
- MALAYSIA (OIC member)
As a pre-cursor for the development of the Halal Pharmaceutical
Standard, in 2009, CCM had supported HDC in conducting the:
HALAL STANDARD: COVERGENCE OF MIND – SHARIAH, SCIENCE & INDUSTRY
This FIRST Halal Pharmaceutical Audit Workshop, was attended by key
organisations:
Regulatory Body National Pharmaceutical Control Bureau, Ministry of Health,
Malaysia
Shariah JAKIM (Department of Islamic Development Malaysia)
Standards 1. SIRIM
2. Standards Malaysia
Industry Selected CCM Halal Council and CCM Halal Committee members
Speakers 1. Science scholars from reputable universities
2. Innovax - CCM’s R&D Centre
Facilitators Halal Integrity Division, HDC
HALAL STANDARD: COVERGENCE OF MIND – SHARIAH, SCIENCE & INDUSTRY
Halal Pharmaceutical Standard: The Development Process
Comm
ittee
Draft
ISC I
Accept
ance
Approva
l by
Minister
Verificatio
n
by
Standard
s
Malaysia
Request for
New
Standard
New Work
Item
Registered
Working
Draft
Written Request was submitted jointly by CCM and HDC in October 2008
August 2009
• Working Group established in September 2009, with
Prof Zhari Ismail of Universiti Sains Malaysia (USM) as
Chairman, HDC as Secretariat and SIRIM as Standards
Writer
• Active members: JAKIM, NPCB* and CCM
August
2010
September
2010
*NPCB=National Pharmaceutical Control Bureau, Ministry of Health, Malaysia
Halal Pharmaceutical Standard: Additional Benefits
1. Closer collaboration and cooperation between 2 regulators
– MOH and JAKIM
2. Strengthen relationship between government agencies –
JAKIM, MOH, Standards Malaysia, HDC – covergence of
mind.
3. The MS2424 may be used as a working document.
4. Creation of platform for multiple supporting documentation
e.g. “The Halal Index©”
Publication : The Halal Index Volume 1 Pig Based Pharmaceuticals Hardcover : 164 pages Publisher : Phytorex Press Sdn. Bhd. (897389 –K) No. 21A, Lorong Rahim Kajai 13, Taman Tun Dr. Ismail 60000 Kuala Lumpur, Malaysia. Language : English ISBN : 978 – 967 – 0103 – 01 – 3 (vol. 1) Dimensions : 176 X 250 X 12 mm Weight : 750g Genre : Reference
...Supporting Publications
While much have been written on the subject of Halal and Haram substances found in food, there is no single work which deals exclusively on Halal and Haram compounds used in the pharmaceutical sector. This publication represents a first dealing with pharmaceutical compounds from porcine (pig based) origins. It is addressed to the Muslim Ummah and all those who serve this market which is currently estimated at USD 100 billion per annum. The content of the book comprises monographs of the compounds may be manufactured. In addition, the therapeutic categories of the compounds and brief narratives are included . Additonal information includes ATC codes, compound synonyms and trade names. The reader is also guided with an extensive bibliography and references together with an accompanying website for updated information.
“This index is indispensible for the Halal regulatory bodies, research and development, manufacturers and a must have item for public
use”
Prof. Dr. Zhari Ismail Professor in Pharmaceutical Chemistry
Chairman for drafting the Malaysian Standards for Halal Pharmaceuticals Guidelines
“Ultimately, we hope users of this book will be able to appreciate the significance and depth of the information to make learned decision in
choosing among the variety of products available”
Y. Bhg. Dato’ Seri Jamil Bidin Chief Executive Officer
Halal Industry Development Corporation
The Global Halal Pharmaceutical Market Potential
>20% of world’s population are Muslims
Source:
*Frost & Sullivan Market Insight 2 April 2008
**PricewaterhouseCoopers Report 13 June 2007
Map from Wikipedia/CIA-The World Factbook
GLOBAL MARKET VALUE for PHARMA INDUSTRY:
2006 = US$607b*
2013(e) = US$818b*
2020 (f) = US$1,300b**
Value Chain Analysis
Higher value activities
Current focus of local pharmaceutical industry
A pharmaceutical industry value chain analysis dictates that the highest
value activity resides at the upstream end of the chain.
Presently, the local generics manufacturers (including CCM), are only
focused in Finished Products manufacturing, Sales and Marketing, and
Distribution.
• Recognition by ingredient suppliers of the
Muslim market
• Recognition that alternatives can be sought
There was a move from bovine into porcine research as
base materials for majority of pharmaceutical products due
to the BSE/mad-cow disease and the porcine based
materials are easily available because of its organised
supply chain for their animal parts in developed countries.
• Sensitizing international agencies on concept
of informed choice, e.g. NPC (National
Prescribing Centre, United Kingdom)
Halal Pharmaceuticals: Industry Impact
INFORMED CHOICE
IN MEDICINE TAKING
- THE NPCB MALAYSIA APPROACH
NPCB = National Pharmaceutical Control Bureau
To declare by Sept ’09
Source/Origin for :
1.API and Excipients
2.Hard (Empty) Gelatin Capsules
3.Soft gelatin capsules
Findings:
1. Capsules declared as non-animal sourced contained bovine/
porcine elements
2. Capsules declared as bovine-sourced contained porcine or
combination of bovine and porcine elements
TRAINING/KNOWLEDGE SHARING
CCM’s Halal Awareness Programme:
1. Halal Awareness Roadshows & Workshops for
Employees
2. Halal Awareness Seminar for Suppliers
3. Halal Talks for Customers
4. Dialogue Sessions with regulatory authorities/
related bodies
KNOWLEDGE = COMMITMENT & SINCERITY
CCM’s Key Focus: Halal Integrity
CAPACITY
BUILDING
HALAL INTEGRITY
MARKETING
“FARDH KIFAYAH”
SHARED RESPONSIBILITY
CCM’s Halal Initiatives: Key Focus
INFORMED
CHOICE
CCM Pharmaceuticals Division: Manufacturing Facilities - Capacity
Oral Solid
Dosage (OSD) Capacity
Tablets 3 billion
Capsules 300 million
Softgel 144 million capsules
Sterile Production Capacity
Ampoules 36 million ampoules
Dental cartridges 7.4 million vials
Vials liquids 3.6 million vials
Eye drops 168,000 litres
Haemodialysis 5 million litres
Irrigation solution 3 million litres
Penicillin Capacity
Tablets 55 million
Capsules 115 million
Powder 72,000 kg
Cephalosporin Capacity
Tablets 144 million
Capsules 36 million
Powder 72,000 kg
SVI vials 2.5 million vials
Other Dosage
Form Capacity
Liquid 2 million litres
Cream 72,000 kg
1
st
1
st 1st
IBC The
only
in
ASEAN
OTHER SIGNIFICANT 1ST IN MALAYSIA
1st SVI (Small Volume Injectibles)
1st Dental Cartridge
1st Soft Gel
1st Patent
• Controlled Release mini-tabs in capsules
1st state-of-art IBC plant
COMING SOON
1st Halal Vaccines F& F
1st Halal Bio-similar
INCREASING HALAL CERTIFIED PRODUCTS
Halal Pharmaceuticals
• Healing is achieved by medicine when the soul
readily accepts it and believes in its usefulness
and in the blessing of healing which Allah s.w.t.
has put into it.
• What is beneficial is that which is blessed and the
most beneficial is that with the greatest blessing.
• And blessed among the people is he from whom
benefit comes wherever he may be.
Ibn Qayyim Al-Jawziyya: Medicine of the Prophet
Conclusion
1. Halal Pharmaceutical is the emerging growth sector
in the Halal industry.
2. There are still a lot of matters to address in terms of
Halal compliance in this industry, and also the
acceptance of the necessity of its Halal certification,
but with good collaboration:
Together
Everyone
Achieves
More